If non-invasive prenatal genetic testing is the beginning of commercial application of genetic testing, the industry has developed for only five years. In five years, companies such as Huada Gene, Berry and Kang have grown rapidly, and the market for non-invasive prenatal genetic testing has reached 1 billion. The next step in the genetic testing company is the cancer cancer market in clinical applications.
.jpg)
With the spread of genetic testing in the medical field, companies in the genetics industry have begun to fission. Does the boom in entrepreneurship and investment mean that the rumors of the genetic industry are really coming?
The entire industry is still very early
Zhou Jun, vice president of Junlian Capital, presented a picture at the NGS Innovation Developers Conference, showing that capital investment in the genetic industry is much higher than the development level of the genetic industry itself, and the development of the genetic industry will also undergo a process of climbing upwards. The bubble of capital will also be squeezed and fall back.
.jpg)
The blue area in the figure represents the genetic industry, the yellow area represents capital investment, and the red dotted line represents the current state of the capital hot market.
Zhou Wei said at the time that genetic testing mainly serves research and clinical, both of which are rigorous and have inherent laws. It is destined that the development of genetic testing will be very long; capital is very sensitive to new things, but always experiences a value. The process of recognizing and rediscovering; the whole industry is still very early, but for entrepreneurs, it is a good time to raise funds, and should fully reserve grain.
As mentioned before, there are currently two types of players on the market, one for technology services and clinical services, and one for the consumer market. These two players have different styles depending on the target customers, but the common one is that the market share of both types of players needs to be improved.
Take the leading Huada gene for technology services and clinical services as an example. Although the entrepreneurial boom in the genetic industry has emerged in recent years, the valuation of Huada shares has gone straight to 100 billion, but its prospectus shows that the company's net profit is not high. In the first half of 2015, the net profit of Huada Gene attributable to the parent company was 75.55 million yuan. In 2014, the net profit for 2013 was 24.56 million yuan and 135.88 million yuan respectively.
The consumer market is also in a "cold" state for genetic testing products. The sales of test products of major gene companies on Taobao are almost zero or single digits.
Young Green Plants Honey Drink
Young Green Plants Honey Drink,Plants Honey Drink,Honey Fruit Tea,Honey Herbal Tea
Hengshui Shanzhi Health Drink Co., Ltd , https://www.grasspowder-sz.com